Sign inJoin waitlistJoin the waitlist

MH

Mark Huberman

Medical Oncology

Credentials: ·

History

Medical Oncology
Internal Medicine

Research

Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer
Journal of Clinical Oncology · 2004 · 888 citations
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial
Annals of Internal Medicine · 1990 · 691 citations
Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
Clinical Cancer Research · 2006 · 494 citations

Daniel Costa
31 papers · 1 as a fellow
Paul VanderLaan
17 papers · 3 as a fellow
Deepa Rangachari
16 papers
Lecia Sequist
10 papers · 1 as a fellow
Michael Kent
9 papers
Adnan Majid
8 papers
Erik Viadero
8 papers
Sidharta Gangadharan
8 papers
JL
Jacob Lokich
6 papers
NY
Norihiro Yamaguchi
6 papers · 6 as a resident
Balazs Halmos
5 papers
MP
Marshall Posner
5 papers